Pfizer-BioNTech COVID-19 vaccine

URI: https://gptkb.org/entity/Pfizer-BioNTech_COVID-19_vaccine

GPTKB entity

Statements (64)

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:age	12 years and older 5-11 years (pediatric formulation)
gptkbp:approvedBy	gptkb:World_Health_Organization gptkb:European_Medicines_Agency gptkb:U.S._Food_and_Drug_Administration
gptkbp:ATCCode	gptkb:J07BX03
gptkbp:boosterFormulation	bivalent (Omicron-adapted) monovalent (original)
gptkbp:boosters	yes
gptkbp:brand	gptkb:Comirnaty
gptkbp:clinicalTrialPhase	July 2020 - November 2020
gptkbp:contains	gptkb:plastic gptkb:ALC-0159 gptkb:ALC-0315 sodium chloride potassium chloride saline sucrose cholesterol lipid nanoparticles 1,2-distearoyl-sn-glycero-3-phosphocholine dibasic sodium phosphate dihydrate monobasic potassium phosphate nucleoside-modified mRNA
gptkbp:countryOfOperation	gptkb:Canada gptkb:European_Union gptkb:United_Kingdom gptkb:United_States many other countries
gptkbp:developedBy	gptkb:Pfizer gptkb:BioNTech
gptkbp:dosageSchedule	two doses, 3 weeks apart
gptkbp:efficacyAgainstOriginalStrain	~95%
gptkbp:emergencyServices	December 2020
gptkbp:firstAdministered	gptkb:Margaret_Keenan
gptkbp:firstAdministeredCountry	gptkb:United_Kingdom
gptkbp:firstAdministeredDate	8 December 2020
gptkbp:fullApprovalDate	August 2021
https://www.w3.org/2000/01/rdf-schema#label	Pfizer-BioNTech COVID-19 vaccine
gptkbp:legalStatus	prescription only
gptkbp:marketedIn	gptkb:Australia gptkb:Canada gptkb:European_Union gptkb:Japan gptkb:United_States many other countries
gptkbp:patent	gptkb:Pfizer gptkb:BioNTech
gptkbp:pregnancyCategory	consult healthcare provider
gptkbp:routeOfAdministration	intramuscular injection
gptkbp:sideEffect	fever fatigue headache muscle pain chills injection site pain
gptkbp:storage	-70°C
gptkbp:target	gptkb:COVID-19
gptkbp:technology	messenger RNA
gptkbp:WHOEmergencyUseListing	December 2020
gptkbp:bfsParent	gptkb:COVID-19 gptkb:COVID-19_pandemic
gptkbp:bfsLayer	4